⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ICCM News
IceCure Medical Ltd. Ordinary Shares
Form 8-K
sec.gov
LFWD
ICCM
IceCure Successfully Completes First Cryoablation Treatment in Its ChoICE Post-Marketing Study for Breast Cancer Cryoablation
prnewswire.com
ICCM
IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense® Breast Cancer Cryoablation at Two U.S. Sites
prnewswire.com
ICCM
IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026
prnewswire.com
ICCM
IceCure Medical Receives Regulatory Approval to Market ProSense® in China
prnewswire.com
ICCM
IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands
prnewswire.com
ICCM
West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation
prnewswire.com
ICCM
IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation
prnewswire.com
ICCM
IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year
prnewswire.com
ICCM
IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment
prnewswire.com
ICCM